<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Over the past 20 years allogeneic bone marrow transplantation has been increasingly utilized in the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0005558'>chronic leukemias</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, severe forms of <z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e>, <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndromes and <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> due to a lack of specific enzymes in the monocyte-macrophage system </plain></SENT>
<SENT sid="1" pm="."><plain>Despite the overall success of this approach and besides the so-called classic complications arising from the toxicity of the conditioning regimen, occurrence of <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">GVH disease</z:e> and <z:hpo ids='HP_0006515'>interstitial pneumonitis</z:hpo>, there are other less common complications which have been reported mainly by teams transplanting on a large number of patients </plain></SENT>
<SENT sid="2" pm="."><plain>With only a limited experience, concerning 60 patients with transplants between May 1987 and May 1991, we have seen some unusual complications such as toxoplasma <z:hpo ids='HP_0002383'>encephalitis</z:hpo>, <z:hpo ids='HP_0003473'>myasthenia</z:hpo> gravis and <z:hpo ids='HP_0010885'>aseptic bone necrosis</z:hpo>, which may give rise to difficult diagnostic and therapeutic decisions </plain></SENT>
</text></document>